Area Under Curve [plocha pod křivkou]

topical
169
Terms

AUC

Persistent link   https://www.medvik.cz/link/D019540
Definition

A statistical means of summarizing information from a series of measurements on one individual. It is frequently used in clinical pharmacology where the AUC from serum levels can be interpreted as the total uptake of whatever has been administered. As a plot of the concentration of a drug against time, after a single dose of medicine, producing a standard shape curve, it is a means of comparing the bioavailability of the same drug made by different companies. (From Winslade, Dictionary of Clinical Research, 1992)

DUI
D019540 MeSH Browser
CUI
M0029025
History note
97
Public note
97

E Analytical, Diagnostic and Therapeutic Techniques and Equipment
E05 Investigative Techniques 209
E05.318 Epidemiologic Methods 1 030
E05.318.740 Statistics as Topic 13 066
E05.318.740.100 Actuarial Analysis 22
E05.318.740.150 Analysis of Variance 491
E05.318.740.200 Area Under Curve 169
E05.318.740.225 Biometry 420
E05.318.740.237 Biostatistics 59
E05.318.740.244 Chemometrics 1
E05.318.740.250 Cluster Analysis 466
E05.318.740.275 Confidence Intervals 82
E05.318.740.300 Data Interpretation, Statistical 3 209
E05.318.740.325 Dimensionality Reduction
E05.318.740.350 Discriminant Analysis 89
E05.318.740.375 Equipment and Supplies Utilization 1
E05.318.740.388 Facilities and Services Utilization 3
E05.318.740.400 Factor Analysis, Statistical 483
E05.318.740.475 Matched-Pair Analysis 20
E05.318.740.500 Models, Statistical 466
E05.318.740.525 Monte Carlo Method 128
E05.318.740.600 Probability 275
E05.318.740.675 Procedures and Techniques Utilization 2
E05.318.740.750 Regression Analysis 669
E05.318.740.872 Sensitivity and Specificity 2 409
E05.318.740.933 Spatial Analysis 26
E05.318.740.994 Statistical Distributions 63
E05.318.740.995 Statistics, Nonparametric 419
E05.318.740.996 Stochastic Processes 116
E05.318.740.998 Survival Analysis 3 040

G Phenomena and Processes
G03 Metabolic Phenomena obsolete
G03.787 Pharmacokinetics 750
G03.787.024 Absorption 273
G03.787.101 Area Under Curve 169
G03.787.151 Biological Availability 286
G03.787.225 Biotransformation 794
G03.787.297 Drug Elimination Routes 7
G03.787.321 Drug Liberation 154
G03.787.559 Therapeutic Equivalency 174
G03.787.917 Tissue Distribution 268
G07 Physiological Phenomena 176
G07.690 Pharmacological and Toxicological Phenomena 59
G07.690.725 Pharmacokinetics 750
G07.690.725.015 Absorption 273
G07.690.725.064 Area Under Curve 169
G07.690.725.129 Biological Availability 286
G07.690.725.225 Biotransformation 794
G07.690.725.249 Chronopharmacokinetics
G07.690.725.297 Drug Elimination Routes 7
G07.690.725.321 Drug Liberation 154
G07.690.725.513 Metabolic Clearance Rate 224
G07.690.725.898 Therapeutic Equivalency 174
G07.690.725.949 Tissue Distribution 268

N Health Care
N06 Environment and Public Health 202
N06.850 Public Health 4 036
N06.850.520 Epidemiologic Methods 1 030
N06.850.520.830 Statistics as Topic 13 066
N06.850.520.830.100 Actuarial Analysis 22
N06.850.520.830.150 Analysis of Variance 491
N06.850.520.830.200 Area Under Curve 169
N06.850.520.830.250 Cluster Analysis 466
N06.850.520.830.275 Confidence Intervals 82
N06.850.520.830.300 Data Interpretation, Statistical 3 209
N06.850.520.830.350 Discriminant Analysis 89
N06.850.520.830.375 Facilities and Services Utilization 3
N06.850.520.830.400 Factor Analysis, Statistical 483
N06.850.520.830.475 Matched-Pair Analysis 20
N06.850.520.830.500 Models, Statistical 466
N06.850.520.830.525 Monte Carlo Method 128
N06.850.520.830.562 Multilevel Analysis 21
N06.850.520.830.600 Probability 275
N06.850.520.830.675 Procedures and Techniques Utilization 2
N06.850.520.830.750 Regression Analysis 669
N06.850.520.830.872 Sensitivity and Specificity 2 409
N06.850.520.830.933 Spatial Analysis 26
N06.850.520.830.994 Statistical Distributions 63
N06.850.520.830.995 Statistics, Nonparametric 419
N06.850.520.830.996 Stochastic Processes 116
N06.850.520.830.998 Survival Analysis 3 040

Back Add